Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Catapult Ventures

Investor type Micro VC
Founders Darren Liccardo Rouz Jazayeri


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 100
Average round size
The average size of a deal this fund participated in
Portfolio companies 76
Rounds per year 4.17
Lead investments 17
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 27
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Health Diagnostics
  • Medical

Catapult Ventures appeared to be the VC, which was created in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Leicester.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Catapult Ventures, startups are often financed by South East Growth Fund & Management, Oxford Capital Partners, Spark Ventures. The meaningful sponsors for the fund in investment in the same round are Midven, Spark Ventures, South East Growth Fund & Management. In the next rounds fund is usually obtained by South East Growth Fund & Management, Oxford Capital Partners, Octopus Ventures.

Besides them, we counted 2 critical employees of this fund in our database.

Among the most successful fund investment fields, there are Pharmaceutical, Clinical Trials. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the various public portfolio startups of the fund, we may underline Abzena plc, AMR Centre, MicroBioSensor

Speaking about the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2008. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2017. Opposing the other organizations, this Catapult Ventures works on 0 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

QV Bioelectronics

Advanced Materials
Health Care
Life Science
Medical Device
$2M10 Jan 2023 Manchester, England, United Kingdom

Urban Machine

Building Material
$5M08 Dec 2022 -

Pickle Robot

Artificial Intelligence
Industrial Manufacturing
$26M15 Nov 2022 Massachusetts, United States

Strella Biotechnology

Big Data
Food and Beverage
Supply Chain Management
$8M07 Jun 2022 Philadelphia, Pennsylvania, United States

Urban Machine

Building Material
$1M12 Nov 2021 -


Medical Device
$363K29 Apr 2021 United Kingdom, England, United Kingdom


Health Care
$4M08 Apr 2021 United Kingdom, England, United Kingdom


Internet of Things
$1M18 Jun 2020 Mountain View, California, United States

Strella Biotechnology

Big Data
Food and Beverage
Supply Chain Management
$3M30 Apr 2020 Philadelphia, Pennsylvania, United States
Oculii Raises $55M in Series B Funding

– Oculii, a maker of high-resolution commercial imaging 4D radar, raised $55M in Series B funding.
– The round was co-led by Catapult Ventures and Conductive Ventures, with participation from Taiwania Capital, Susquehanna Investment Group (SIG), HELLA Ventures, PHI-Zoyi Capital, R7 Partners, VectoIQ, ACVC Partners, Mesh Ventures, SV Tech Ventures, Schox Ventures, and Signature Bank.
– The new funding will be used to scale and deliver on demand of Tier-1’s and OEMs globally.

Maxwellia Raises £3.2M in Funding

– Maxwellia is an Alderley Park, UK-based self-care company.
– The company raised £3.2m in funding led by Praetura Ventures with participation from the Future Fund, Catapult Ventures, Alderley Park Ventures and Biocity along with individual and angel investors.
– The new investment will be used to scale up the manufacture and rollout of drugs following MHRA approval.
– Maxwellia’s chief executive Anna Maxwell is a pharmacist with over 20 years’ experience.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Catapult Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: